What’s New

Latest News

News
Epcoritamab Plus Lenalidomide and Rituximab Improves PFS in Relapsed Follicular Lymphoma
02/23/2026
Grace Taylor, MS, MA
Key Clinical Summary Phase 3 EPCORE FL-1 trial met dual primary endpoints, demonstrating superior overall response rate (95% vs 79%) and progression-free survival (PFS) with epcoritamab plus lenalidomide and rituximab (R2) vs R2...
Key Clinical Summary Phase 3 EPCORE FL-1 trial met dual primary endpoints, demonstrating superior overall response rate (95% vs 79%) and progression-free survival (PFS) with epcoritamab plus lenalidomide and rituximab (R2) vs R2...
Key Clinical Summary Phase...
02/23/2026
First Report Managed Care
First Report Managed Care
News
VA Lifestyle Program Linked to Improved Cardiometabolic Risk
02/23/2026
Hannah Musick
A 15-week US Department of Veterans Affairs (VA)-based lifestyle program emphasizing a whole foods and plant-based diet, physical activity, and stress management was associated with significant improvements in cardiometabolic risk factors...
A 15-week US Department of Veterans Affairs (VA)-based lifestyle program emphasizing a whole foods and plant-based diet, physical activity, and stress management was associated with significant improvements in cardiometabolic risk factors...
A 15-week US Department of...
02/23/2026
Veterans Health Today
Veterans Health Today
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
Vascular Disease Management
News
BIOTRONIK Receives FDA Approval for Solia CSP S, World’s First Pacing Lead Specifically Designed For LBBAP 
02/23/2026
BIOTRONIK Press Release BIOTRONIK, a global leader in cardiovascular medical technology, today announced its Solia CSP S pacing lead has received approval from the U.S. Food and Drug Administration (FDA). With this approval, Solia CSP S is...
BIOTRONIK Press Release BIOTRONIK, a global leader in cardiovascular medical technology, today announced its Solia CSP S pacing lead has received approval from the U.S. Food and Drug Administration (FDA). With this approval, Solia CSP S is...
BIOTRONIK Press...
02/23/2026
EP Lab Digest
EP Lab Digest
a colorful illustration of the brain
News
Five-Year Ublituximab Efficacy Sustained in Relapsing MS Trial
02/23/2026
Maria Mantas
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained...
02/23/2026
Neurology
Neurology
FDA Approval
FDA Approves Acalabrutinib Plus Venetoclax for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
02/20/2026
Emily Estrada
Based on results from the phase 3 AMPLIFY trial, the FDA has approved acalabrutinib plus venetoclax for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Based on results from the phase 3 AMPLIFY trial, the FDA has approved acalabrutinib plus venetoclax for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Based on results from the phase...
02/20/2026
Oncology
Oncology
News
Neighborhood Socioeconomic Status Tied to Survival in US Early-Onset Metastatic Colorectal Cancer
02/19/2026
Hannah Musick
In a US community-based cohort of young adults with metastatic colorectal cancer, lower neighborhood socioeconomic status was independently associated with significantly higher mortality, highlighting the impact of structural disadvantage on...
In a US community-based cohort of young adults with metastatic colorectal cancer, lower neighborhood socioeconomic status was independently associated with significantly higher mortality, highlighting the impact of structural disadvantage on...
In a US community-based cohort...
02/19/2026
Journal of Clinical Pathways
Journal of Clinical Pathways

Latest Research

Cover Story Jan/Feb
The Dermatologist
Forward Focus: Top Trends in Dermatology for 2026
Vol. 34, Issue 1, Issue February 2026
CLD 2026 Jan Feb cover..png
Cath Lab Digest
Impact of TAVR on Functional vs. Degenerative Mitral Regurgitation
Vol. 34, Issue 1, Issue February 2026

HMP Global Learning Network

Featured Interviews

Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
02/01/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
02/01/2026
Vascular Disease Management
tourniquet stop the bleed DeBoer
Videos
Pediatric Video Tutorial: Stop the Bleed Part 2—Tourniquet Tips
01/30/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets,...
01/30/2026
EMSWorld
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network APP Institute
CTP News Desk hero image
Viewpoints
Avoiding Audits and Making Sure You Get Paid
01/30/2026
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits,...
01/30/2026
Wounds
Alison Schram, MD, Memorial Sloan Kettering Cancer Center
Videos
Treating NRG1 Fusion-Positive Non-Small Cell Lung Cancer
01/02/2026
Alison Schram, MD
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the...
01/02/2026
Oncology
Matthew Regulski, DPM, FFPM, RCPS (Glasgow), DABMSP
Viewpoints
Cutting Costs, Raising Standards: The Case for Evidence-Based CTP Use
12/30/2025
Matthew J. Regulski, DPM, ABMSP, CMET, FAPWH(c)
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are...
12/30/2025
Wounds
Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
CTP News Desk Image
Viewpoints
Observations on Potential Pivots and Continued Change
12/01/2025
Scott Nelson
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on...
12/01/2025
Wounds
Corey Siegel
Conference Coverage
Corey Siegel, MD, on Improving IBD Care Models
11/28/2025
Corey A. Siegel, MD, MS
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke...
11/28/2025
Advances in Inflammatory Bowel Disease Network
BDHC thumbnail
Videos
Breaking Down Cancer Prevention: What Really Works?
11/26/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down...
11/26/2025
Cancer Care Business Exchange

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use